Colgate-Palmolive's first-quarter results show earnings per share of $0.74, in line with estimates, but revenues of $4.399 billion fell short of the $4.417 billion consensus. This disappointing performance has led to a 4.6% decline in shares during pre-market trading. The company faces ongoing challenges from the COVID-19 pandemic and rising costs, prompting a revision of its full-year sales and earnings expectations.
“Colgate-Palmolive Company (NYSE:CL) · declared a quarterly cash dividend of · $0.47 · per share of common stock”
“Colgate-Palmolive Company · reported · first-quarter 2022 results · in line with the Zacks Consensus Estimate”
“Colgate-Palmolive Company · reported · earnings per share · declined”
“Colgate-Palmolive Company · reported · sales · missed the Zacks Consensus Estimate”
“Colgate-Palmolive Company · expects · uncertainties from the COVID-19 pandemic · to continue in 2022”
“Colgate-Palmolive Company · expects · funding growth and revenue growth management initiatives · to be more relevant”
“Colgate-Palmolive Company · saw · shares slip · 4.6%”
“Colgate-Palmolive Company · reported · net sales · $4,399 million”
“Colgate-Palmolive Company · reported · sales growth · 1.5% from the year-ago quarter”
“Colgate-Palmolive Company · has reached · global market share in the manual toothbrushes category · 30.7%”
“Colgate-Palmolive Company · holds · market share in the global toothpaste market · 39.2%”
“Colgate-Palmolive Company · ended · first-quarter 2022 with cash and cash equivalents · $877 million”